Skip to main content

Table 1 The baseline characteristics of 154 cases of recurrent/metastatic head and neck squamous cell carcinoma patients

From: The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study

Characteristic

Cases (n)

Age (years)

<60

116

(75.3%)

≥ 60

38

(24.7%)

Gender

  

Male

140

(90.0%)

Female

14

(10.0%)

Primary Site

  

Tongue

53

(34.4%)

Buccal

41

(26.6%)

Larynx

18

(11.7%)

Laryngopharynx

14

(9.1%)

Oropharynx

8

(5.2%)

Palate

3

(1.9%)

Maxillary Sinus

3

(1.9%)

Floor of the Mouth

2

(1.3%)

Nasal Cavity

1

(0.6%)

ECOG PS Score

  

1

152

(98.7%)

2

2

(1.3%)

CPS Score

  

<1

16

(10.4%)

≥ 1, <20

22

(14.3%)

≥ 20

74

(48.1%)

Unknown

42

(27.3%)

Recurrence/Metastasis

  

Local Recurrence Only

104

(67.5%)

Distant Metastasis Only

26

(16.9%)

Local and Distant

24

(15.6%)

HPV Infection Status

  

Negative

68

(44.2%)

Positive

17

(11.0%)

Unknown

69

(44.8%)